Utilization of 3D mapping systems in interventional electrophysiology and its impact on procedure time and fluoroscopy-Insights from the "Go for Zero Fluoroscopy" project.
3D mapping
catheter ablation
fluoroscopy
interventional electrophysiology
zero radiation
Journal
Pacing and clinical electrophysiology : PACE
ISSN: 1540-8159
Titre abrégé: Pacing Clin Electrophysiol
Pays: United States
ID NLM: 7803944
Informations de publication
Date de publication:
08 2023
08 2023
Historique:
revised:
11
06
2023
received:
20
03
2023
accepted:
03
07
2023
medline:
14
8
2023
pubmed:
24
7
2023
entrez:
24
7
2023
Statut:
ppublish
Résumé
The implementation of 3D mapping systems plays an important role in interventional electrophysiology (EP) in recent years. The aim of the present study was to evaluate use of 3D mapping systems regarding fluoroscopy and procedure duration. In the "Go for Zero Fluoroscopy" project 25 European centers provided data of consecutive EP procedures. Data on use of 3D mapping systems as well as utilization of contact force catheters and multipolar mapping catheters were associated with fluoroscopy time, dose area product (DAP), and procedure duration. A 3D mapping system was used in 966 (54%) cases. Use of 3D mapping for atrioventricular nodal reentry tachycardia (AVNRT) was associated with reduced fluoroscopy time (p < 0.001), DAP (p = 0.04) but increased procedure time (p = 0.029). Moreover, fluoroscopy time (p < 0.001) and DAP (p = 0.005) were significantly lower in the 3D mapping group in ablation of typical atrial flutter. However, the procedure time (p < 0.001) increased. Use of 3D mapping in the ablation of accessory pathway (AP) was associated with reduced fluoroscopy time (p < 0.001) and DAP (p < 0.001) with no significant increase in procedure time (p = 0.066). In the case of atrial fibrillation, a 3D mapping system was used in 485 patients (75.8%). Additional use of a contact force catheter was associated with lower fluoroscopy time (p < 0.001) and DAP (p < 0.001). Use of a multipolar mapping catheter was associated with lower fluoroscopy time (p = 0.002). The implementation of 3D mapping systems in the ablation of ventricular tachycardias resulted in a significant increase in the procedure time (p = 0.001) without significant differences regarding the DAP (p = 0.773) and fluoroscopy time (p = 0.249). Use of 3D mapping systems in ablation of supraventricular tachycardias is associated with lower radiation exposure. Nevertheless, the procedure time often increases, except in the case of ablation for AP. Use of contact force catheters and multipolar mapping catheters is associated with yet lower radiation exposure values. Prospective randomized studies are needed to further elucidate potential benefit of these technological tools.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
875-881Informations de copyright
© 2023 The Authors. Pacing and Clinical Electrophysiology published by Wiley Periodicals LLC.
Références
Rotter M, Takahashi Y, Sanders P, et al. Reduction of fluoroscopy exposure and procedure duration during ablation of atrial fibrillation using a novel anatomical navigation system†. Eur Heart J. 2005;26:1415-1421. doi:10.1093/eurheartj/ehi172
Estner HL, Deisenhofer I, Luik A, et al. Electrical isolation of pulmonary veins in patients with atrial fibrillation: reduction of fluoroscopy exposure and procedure duration by the use of a non-fluoroscopic navigation system (NavX®). EP Europace. 2006;8:583-587. doi:10.1093/europace/eul079
Bourier F, Vlachos K, Lam A, et al. Three-dimensional image integration guidance for cryoballoon pulmonary vein isolation procedures. J Cardiovasc Electrophysiol. 2019;30:2790-2796. doi:10.1111/jce.14249
Krzowski B, Gawałko M, Peller M, et al. Radiation safety and electrophysiologists: radiation protection status - Go for Zero Fluoroscopy european heart rhythm association registry. Cardiology. 2021;146:600-606. doi:10.1159/000517000
Josephson ME, Anter E. Substrate mapping for ventricular tachycardia: assumptions and Misconceptions. JACC Clin Electrophysiol. 2015;1:341-352. doi:10.1016/j.jacep.2015.09.001
Cauti FM, Rossi P, C LaGreca, et al. Minimal fluoroscopy approach for right-sided supraventricular tachycardia ablation with a novel ablation technology: insights from the multicenter CHARISMA clinical registry. J Cardiovasc Electrophysiol. 2021;32:1296-1304. doi:10.1111/jce.15023
Reents T, Jilek C, Schuster P, et al. Multicenter, randomized comparison between magnetically navigated and manually guided radiofrequency ablation of atrioventricular nodal reentrant tachycardia (the MagMa-AVNRT-trial). Clin Res Cardiol. 2017;106:947-952. doi:10.1007/s00392-017-1144-8
Robaye B, Deceuninck O, Blommaert D, et al. 3D navigation system allows remarkable reduction in fluoroscopy use during cavo-tricuspid isthmus ablation. J Interv Card Electrophysiol. 2021;61:333-338. doi:10.1007/s10840-020-00818-7
Kosiuk J, Fiedler L, Ernst S, et al. Fluoroscopy usage in contemporary interventional electrophysiology: insights from a European registry. Clin Cardiol. 2021;44:36-42. doi:10.1002/clc.23411
Picano E, Piccaluga E, Padovani R, et al. Risks related to fluoroscopy radiation associated with electrophysiology procedures. J Atr Fibrillation. 2014;7:1044. doi:10.4022/jafib.1044
Demo H, Aranda C, Razminia M. Fluoroless left atrial access for radiofrequency and cryoballoon ablations using a novel radiofrequency transseptal wire. J Interv Card Electrophysiol. 2022;64:183-190. doi:10.1007/s10840-022-01157-5
Topalovic M, Prolic Kalinsek T, Zizek D, et al. Zero-fluoroscopy catheter ablation of supraventricular tachycardias in pediatric population. EP Europace. 2022;24. doi:10.1093/europace/euac053.314
Ceresnak SR, Dubin AM, Kim JJ, et al. Success rates in pediatric WPW ablation are improved with 3-dimensional mapping systems compared with fluoroscopy alone: a multicenter study. J Cardiovasc Electrophysiol. 2015;26:412-416. doi:10.1111/jce.12623
Telishevska M, Hebe J, Paul T, et al. Catheter ablation in ASymptomatic PEDiatric patients with ventricular preexcitation: results from the multicenter “CASPED” study. Clin Res Cardiol. 2019;108:683-690. doi:10.1007/s00392-018-1397-x
Dengke Z, Lan L, Xiangli S, Shubin J. Treatment of left accessory cardiac pathway conduction disorders using radiofrequency catheter ablation under the guidance of the Ensite NavX 3D mapping system: a retrospective study. Int J Cardiovasc Imaging. 2019;35:387-392. doi:10.1007/s10554-018-1449-3
Huang HD, Rodriguez JM, Serafini NJ, et al. Comparison between minimal fluoroscopy and conventional approaches for visually guided laser balloon pulmonary vein isolation ablation. J Cardiovasc Electrophysiol. 2020;31:1608-1615. doi:10.1111/jce.14546
Iliodromitis K, Lenarczyk R, Scherr D, et al. Patient selection, peri-procedural management, and ablation techniques for catheter ablation of atrial fibrillation: an EHRA survey. EP Europace. 2022;25:667-675. doi:10.1093/europace/euac236
Varnavas V, De Schouwer K, Abugattas JP, Wolf M, De Greef Y, Schwagten B. 3D mapping versus cardiac computed tomography guided cryoballoon ablation for atrial fibrillation. EP Europace. 2021;23. doi:10.1093/europace/euab116.214
Antolic B, Jan M, Vrbajnscak M, Zizek D, Kajdic N. Fluoroless ablation of atrial fibrillation using intracardiac ultrasound integrated with 3D electroanatomical mapping system. EP Europace. 2021;23. doi:10.1093/europace/euab116.244
Gras M, Garcia R, Waldmann V, et al. Independent factors of low radiation dose during atrial fibrillation ablation with cryoballoon or radiofrequency: results from the “Go for zero fluoroscopy” registry. Pacing Clin Electrophysiol. 2021;44:1853-1860. doi:10.1111/pace.14366
Cronin EM, Bogun FM, Maury P, et al. 2019 HRS/EHRA/APHRS/LAHRS expert consensus statement on catheter ablation of ventricular arrhythmias. Heart Rhythm. 2019;21:1143-1144. doi:10.1093/europace/euz132
Elbatran AI, Li A, Gallagher MM, et al. Contact force sensing in ablation of ventricular arrhythmias using a 56-hole open-irrigation catheter: a propensity-matched analysis. J Interv Card Electrophysiol. 2021;60:543-553. doi:10.1007/s10840-020-00756-4
Di Biase L, Burkhardt JD, Lakkireddy D, et al. Ablation of stable VTs versus substrate ablation in ischemic cardiomyopathy: the VISTA randomized multicenter trial. J Am Coll Cardiol. 2015;66:2872-2882. doi:10.1016/j.jacc.2015.10.026
Fernández-Armenta J, Penela D, Acosta J, et al. Substrate modification or ventricular tachycardia induction, mapping, and ablation as the first step? Heart Rhythm. 2016;13:1589-1595. doi:10.1016/j.hrthm.2016.05.013